575 related articles for article (PubMed ID: 30636477)
1. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
[TBL] [Abstract][Full Text] [Related]
2. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
Rahmutula D; Zhang H; Wilson EE; Olgin JE
Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
[TBL] [Abstract][Full Text] [Related]
3. Impaired sinoatrial node function and increased susceptibility to atrial fibrillation in mice lacking natriuretic peptide receptor C.
Egom EE; Vella K; Hua R; Jansen HJ; Moghtadaei M; Polina I; Bogachev O; Hurnik R; Mackasey M; Rafferty S; Ray G; Rose RA
J Physiol; 2015 Mar; 593(5):1127-46. PubMed ID: 25641115
[TBL] [Abstract][Full Text] [Related]
4. Distinct patterns of atrial electrical and structural remodeling in angiotensin II mediated atrial fibrillation.
Jansen HJ; Mackasey M; Moghtadaei M; Belke DD; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
J Mol Cell Cardiol; 2018 Nov; 124():12-25. PubMed ID: 30273558
[TBL] [Abstract][Full Text] [Related]
5. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors.
Springer J; Azer J; Hua R; Robbins C; Adamczyk A; McBoyle S; Bissell MB; Rose RA
J Mol Cell Cardiol; 2012 May; 52(5):1122-34. PubMed ID: 22326431
[TBL] [Abstract][Full Text] [Related]
6. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice.
Bohne LJ; Jansen HJ; Daniel I; Dorey TW; Moghtadaei M; Belke DD; Ezeani M; Rose RA
Heart Rhythm; 2021 Jan; 18(1):118-129. PubMed ID: 32911049
[TBL] [Abstract][Full Text] [Related]
7. Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts.
Liu Y; Lv H; Tan R; An X; Niu XH; Liu YJ; Yang X; Yin X; Xia YL
Hypertension; 2020 Dec; 76(6):1856-1867. PubMed ID: 33175633
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic Peptide Receptor B Protects Against Atrial Fibrillation by Controlling Atrial cAMP Via Phosphodiesterase 2.
Dorey TW; Liu Y; Jansen HJ; Bohne LJ; Mackasey M; Atkinson L; Prasai S; Belke DD; Fatehi-Hassanabad A; Fedak PWM; Rose RA
Circ Arrhythm Electrophysiol; 2023 Nov; 16(11):e012199. PubMed ID: 37933567
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of connective tissue growth factor in human atrial fibrillation and angiotensin II-treated cardiomyocytes.
Ko WC; Hong CY; Hou SM; Lin CH; Ong ET; Lee CF; Tsai CT; Lai LP
Circ J; 2011; 75(7):1592-600. PubMed ID: 21576830
[TBL] [Abstract][Full Text] [Related]
10. Effects of Wild-Type and Mutant Forms of Atrial Natriuretic Peptide on Atrial Electrophysiology and Arrhythmogenesis.
Hua R; MacLeod SL; Polina I; Moghtadaei M; Jansen HJ; Bogachev O; O'Blenes SB; Sapp JL; Legare JF; Rose RA
Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1240-54. PubMed ID: 26227000
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteasome Subunit β5i Promotes Ang II (Angiotensin II)-Induced Atrial Fibrillation by Targeting ATRAP (Ang II Type I Receptor-Associated Protein) Degradation in Mice.
Li J; Wang S; Zhang YL; Bai J; Lin QY; Liu RS; Yu XH; Li HH
Hypertension; 2019 Jan; 73(1):92-101. PubMed ID: 30571551
[TBL] [Abstract][Full Text] [Related]
12. Renal Natriuretic Peptide Receptor-C Deficiency Attenuates NaCl Cotransporter Activity in Angiotensin II-Induced Hypertension.
Shao S; Li XD; Lu YY; Li SJ; Chen XH; Zhou HD; He S; Guo YT; Lu X; Gao PJ; Wang JG
Hypertension; 2021 Mar; 77(3):868-881. PubMed ID: 33486984
[TBL] [Abstract][Full Text] [Related]
13. Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.
Polina I; Jansen HJ; Li T; Moghtadaei M; Bohne LJ; Liu Y; Krishnaswamy P; Egom EE; Belke DD; Rafferty SA; Ezeani M; Gillis AM; Rose RA
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7990-8000. PubMed ID: 32198206
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin I
Zhang Y; Yuan M; Cai W; Sun W; Shi X; Liu D; Song W; Yan Y; Chen T; Bao Q; Zhang B; Liu T; Zhu Y; Zhang X; Li G
Cell Mol Life Sci; 2024 Jun; 81(1):264. PubMed ID: 38878214
[TBL] [Abstract][Full Text] [Related]
15. Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.
Zhao H; Li T; Liu G; Zhang L; Li G; Yu J; Lou Q; He R; Zhan C; Li L; Yang W; Zang Y; Cheng C; Li W
J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):575-585. PubMed ID: 31159577
[TBL] [Abstract][Full Text] [Related]
16. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
[TBL] [Abstract][Full Text] [Related]
17. Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice.
Wang Y; Gu YH; Ren KW; Xie X; Wang SH; Zhu XX; Wang L; Yang XL; Bi HL
Hypertens Res; 2024 May; 47(5):1309-1322. PubMed ID: 38374239
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptides regulate heart rate and sinoatrial node function by activating multiple natriuretic peptide receptors.
Azer J; Hua R; Vella K; Rose RA
J Mol Cell Cardiol; 2012 Nov; 53(5):715-24. PubMed ID: 22960454
[TBL] [Abstract][Full Text] [Related]
19. Regional and temporal progression of atrial remodeling in angiotensin II mediated atrial fibrillation.
Jansen HJ; McRae MD; Mackasey M; Rose RA
Front Physiol; 2022; 13():1021807. PubMed ID: 36388100
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
